The IPO could value the company at more than $1 billion, according to the report.
Barclays, Goldman Sachs and William Blair are serving as the lead underwriters of the offering.
More articles on ASC issues:
4 recent ASC acquisitions
ASC leaders: Beware of benchmarks
Florida’s 23-hour stay legislation: ASC boon, hospital bane
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
